Urgent.News

What's breaking now, across thousands of outlets.

Health & Medicine

New Migraine Prevention Guidance Highlights CGRP Drugs, Broad Eligibility

(MedPage Today) -- New guidance from the American Academy of Neurology (AAN) and the American Headache Society (AHS) aims to help clinicians identify which migraine prevention drugs may be most effective for certain patients. The guidelines ...

New Migraine Prevention Guidance Highlights CGRP Drugs, Broad Eligibility

We haven't written up this one. MedPage Today has the full story — the link below goes straight to it.

Read the original at medpagetoday.com →

More in Health & Medicine

Trump inks deal with 9 pharmaceutical companies to lower drug costs

The White House said the agreements will reduce costs to treat Parkinson's disease, macular degeneration, glaucoma, liver disease and other illnesses.

  • Trump extends deals with 9 more pharma companies to lower drug costs
  • Agreements expected to save Americans over $600 billion
  • 26 companies committed to lower prices, representing 90% of market

More from Monday 31 August →